KRT17 and neoplasm: Depending on the major source of CXCR3 ligands in the tumors, K17 may play opposite roles in the total production of these ligands in tumors due to its opposite regulation for intrinsic ligand production in tumor cells vs. extrinsic ligand production in immune cells.